Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Recensioni
Recensioni dei clienti
Application Protocols
No vendor-validated protocols are provided in the Product Data for this specific item. Below is general, literature-based guidance (to be optimized per system):
Protein PEGylation via reductive amination (example outline):
Dissolve protein at 1–10 mg/mL in 50 mM phosphate, pH 6.5; add 150 mM NaCl if needed for stability.
Dissolve mPEG propionaldehyde in minimal water or water/DMSO; add to protein to give 1.2–3 equiv per accessible amine (titrate empirically).
Equilibrate 15–30 min, then add NaBH3CN to 25–50 mM final while gently mixing.
React 2–4 h at room temperature (or 4°C overnight for sensitive proteins).
Quench with 50 mM ethanolamine (pH 8.5) and purify by dialysis/UF.
Oxime ligation to aminooxy-modified biomolecule:
Prepare 50 mM sodium acetate buffer, pH 4.9; add 10 mM aniline.
Combine aminooxy substrate (e.g., 0.1–1 mM) with 1.1–2 equiv mPEG-CHO.
Incubate 1–2 h at room temp; analyze by MS or SEC.
Note: These outlines are informational and not product-specific instructions. Validate conditions on a small scale before preparative work. For research use only.
Biological Roles
This section provides general biochemical context (not product-specific claims).
PEG as a biomaterials modifier (literature): Poly(ethylene glycol) is widely regarded as biologically inert and nonionic; its hydration shell and conformational flexibility reduce protein adsorption and cell adhesion. This “stealth” behavior is exploited to minimize nonspecific interactions in assays, biosensors, and nanomaterials.
Aldehyde reactivity toward biomolecules: The propionaldehyde terminus reacts with primary amines on lysine side chains or N-termini to form imines that can be stabilized by in situ reduction (reductive amination). With hydrazides or aminooxy groups introduced on biomolecules, hydrazones/oximes form efficiently under mild conditions.
Effects on biomacromolecules (research context): PEGylation can enhance aqueous solubility of hydrophobic proteins/peptides, reduce aggregation, and modulate isoelectric behavior without directly altering the active site when placed judiciously. Chain length (nominal MW) and grafting density govern the hydrodynamic radius and steric shielding.
Surface biointerfaces: Aldehyde-PEG grafts to amine-functional surfaces (e.g., aminated glass, silica, or polymer films) create protein-resistant layers, useful in ELISA plates, microarrays, and microfluidic channels.
Note: All uses are for research and laboratory applications only. Actual biological effects depend on the biomolecule, conjugation site, and degree of modification; optimization and empirical validation are essential.
Buffer Applications
mPEG propionaldehyde is not itself a buffering reagent. However, selecting appropriate buffers is critical for its conjugation chemistry (literature guidance):
Reductive amination (amine targets):
Buffer: 50–100 mM sodium phosphate or HEPES, pH 6.0–7.0 (avoid primary amine buffers like Tris).
Additives: 50–100 mM NaBH3CN or suitable alternative reductant added last; 100–150 mM NaCl for protein stability if needed.
Notes: Maintain pH near 6.5 to balance imine formation and protein stability.
Catalyst: 10–50 mM aniline (or p-aminobenzoic acid anilide) to accelerate imine formation (optional but beneficial).
Notes: Oxime formation is generally faster and more stable than hydrazone at similar pH.
Practical buffer tips:
Degas buffers and filter-sterilize (0.22 µm) when working with proteins.
Avoid competing nucleophiles (amine-containing buffers, azide) and carbonyl-reactive preservatives.
After coupling, quench unreacted aldehyde with 10–50 mM hydroxylamine (pH 5) or 50 mM ethanolamine (pH 8.5), then dialyze/UF to exchange into storage buffer.
These are general, literature-based recommendations and should be optimized for each substrate.
Green Alternatives
mPEG propionaldehyde reactions can often be run in predominantly aqueous media, minimizing reliance on high-toxicity organic solvents.
Greener solvent strategies (literature):
Primary choice: Water or aqueous acetate/phosphate buffers for hydrazone/oxime ligation and reductive amination, respectively.
Co-solvents: If needed for solubility, use minimal volumes of ethanol or isopropanol before resorting to DMF/DMSO/ACN. Incrementally increase to ≤10–30% v/v while monitoring protein or substrate stability.
Catalyst selection:
Aniline and derivatives accelerate imine formation; use at low millimolar levels to reduce environmental load. Remove by dialysis or ultrafiltration post-reaction.
Process considerations:
Run at ambient temperature to conserve energy; viscous PEG solutions may benefit from gentle warming (≤30–37°C).
Employ dialysis/UF instead of precipitation for purification when feasible, reducing solvent waste.
Comparison (general):
Aqueous bioconjugation vs. anhydrous organic media
Cons (aqueous): Possible hydrolysis or reversibility of imine intermediates; may require catalysts and careful pH control.
Pros (anhydrous DMF/DMSO): Faster kinetics for some pairings, precise stoichiometry.
Cons (anhydrous): Toxic solvents, higher E-factor from solvent-intensive workups.
Takeaway: Favor buffered water as the reaction medium whenever substrate stability allows; supplement with low-toxicity alcohol cosolvents before high-boiling aprotic solvents.
Pharmaceutical Uses
No therapeutic uses are claimed for this product. The following provides general formulation/manufacturing context for research discussions only.
Excipient and materials context (literature): PEGs are widely used as excipients (solubilizers, plasticizers, bases) in pharmacopeial contexts; however, functionalized PEGs like mPEG propionaldehyde are specialty conjugation reagents rather than standard excipients.
Research/manufacturing roles:
PEGylation of candidate biologics (proteins, peptides) in process development to assess effects on solubility, stability, and manufacturability.
Surface passivation of device components (membranes, tubing, sensor chips) to reduce fouling in process analytical setups.
Prototype polymer–API conjugates for release-rate studies and ADME-like assessments in preclinical research (no clinical claims).
Regulatory considerations (general): Base PEGs have compendial monographs (e.g., USP/NF) by MW classes, but aldehyde-functionalized PEGs typically do not; they are controlled via internal specifications (PDI, end-group content, residuals) and characterized by SEC, NMR, and carbonyl assays.
Process practicality:
Preference for aqueous coupling and benign buffers simplifies scale-up cleaning and waste management.
Robust quenching and purification (dialysis/UF) are essential to remove catalysts/reductants from conjugates before further testing.
Physical Properties
Item-specific physicochemical specifications (bp, mp, density, refractive index, UV cutoff, pKa/logP): Not specified for this item; refer to CoA/Spec Sheet.
General/literature characteristics for mPEG derivatives (informational, not product specifications):
Physical state: Depends on nominal MW. Lower-MW mPEGs can be viscous liquids or waxy solids; higher-MW are waxy/solid with broad softening ranges (polymers do not exhibit sharp melting points).
Solubility: Highly soluble in water and polar organic solvents (e.g., methanol, ethanol, acetone, acetonitrile, DMSO, DMF); limited solubility in nonpolar solvents (e.g., hexanes, toluene). Aldehyde functionality does not materially reduce aqueous solubility at typical PEG MWs.
Hygroscopicity: PEG chains absorb moisture; aldehydes can form hydrates in aqueous media (reversible) and can oxidize to acids upon prolonged exposure to air.
Viscosity: Strongly increases with concentration and MW; solutions are typically Newtonian at low concentration, showing pronounced viscosity growth above ~10–20 wt% (literature trend).
Thermal behavior: PEG glass transition and softening depend on MW and hydration; aldehyde terminus does not substantially change bulk thermal transitions relative to parent mPEG of the same MW.
Stability considerations: Aldehyde groups are sensitive to oxidation and nucleophilic addition; in anhydrous, inert conditions, stability is markedly improved (literature).
Quality and Grades
Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet.
Interpretation and typical quality attributes for mPEG propionaldehyde (general guidance):
Polydispersity (PDI): As a polymeric reagent, mPEG exhibits a molecular weight distribution. Suppliers typically report Mn/Mw and PDI; tighter PDI improves batch-to-batch consistency in conjugation stoichiometry.
Functionalization (end-group) content: Aldehyde substitution is often reported as mol% functionalization or mmol aldehyde per gram. High end-group fidelity is critical for predictable conjugation yields.
Residuals and impurities: Common quality controls include residual solvents (e.g., toluene, DMF), unfunctionalized mPEG, low-MW PEG oligomers, and aldehyde oxidation products (acids/hemiacetals). For bioconjugation use, low levels of these impurities are preferred.
Water and volatiles: Moisture promotes aldehyde hydration; Karl Fischer moisture and LOD may be reported on the CoA. Where low-water content is required, pre-dry under vacuum.
Stabilization: This product is provided argon charged and recommended to be protected from light (from Product Data), which is consistent with preserving aldehyde integrity.
Analytical verification (typical): 1H NMR (end-group signals for –CHO near ~9–10 ppm and PEG backbone at ~3.5 ppm), 13C NMR (carbonyl near ~200 ppm), SEC/GPC for MW distribution, and colorimetric aldehyde assays (e.g., hydroxylamine methods). These are general methods; specific acceptance criteria are item-dependent and should be taken from the CoA.
Reaction and Applications
mPEG propionaldehyde is designed for covalent attachment to nucleophile-bearing substrates, enabling PEGylation and surface passivation.
Key reaction manifolds (literature, general guidance):
Reductive amination with primary amines:
Mechanism: Aldehyde + R–NH2 → imine (Schiff base), then selective reduction to secondary amine.
Reductants: Sodium cyanoborohydride (NaBH3CN) at pH 6–7; alternatively, picoline borane or sodium triacetoxyborohydride in appropriate media.
Applications: PEGylation of lysine residues on proteins/peptides, amine-functional polymers, and nanoparticles.
Hydrazone/oxime ligation:
Partners: Hydrazides (–CONHNH2) or aminooxy (–ONH2) groups.
Conditions: Mildly acidic buffers (acetate pH 4.5–5.5) with aniline catalysis (≤10–50 mM) to accelerate imine formation; oximes generally form faster and are more hydrolytically stable than hydrazones.
Acetal protection/formation (less common in use): Aldehydes can form hemiacetals/acetals with diols under acid catalysis; typically avoided in aqueous bioconjugation unless purposeful.
Applications:
Protein and peptide PEGylation to modulate solubility, reduce nonspecific interactions, and tune pharmacokinetic-like properties in research models (no clinical claims).
Surface modification of beads, membranes, quantum dots, and metal or silica nanoparticles to impart stealth and antifouling behavior.
Preparation of PEGylated linkers/adapters for supramolecular assemblies or polymer–drug conjugate research.
Practical guidance:
Use slight molar excess of aldehyde PEG (1.1–5 equiv per target amine) for heterogeneous surfaces; titrate for proteins to limit over-PEGylation.
Exclude competing amines (buffers and additives). Quench unreacted aldehyde with hydroxylamine or ethanolamine after coupling.
Reaction Conditions
General, literature-based conditions for common couplings of mPEG propionaldehyde (optimize per substrate; not product specifications):
Reductive amination (to primary amines):
Solvent/buffer: 50–100 mM phosphate, pH 6.0–7.0; optional 0–30% DMSO for solubility.
Stoichiometry: 1.1–5.0 equiv mPEG-CHO per amine site (lower for proteins to avoid overlabeling).
Reductant: 10–100 mM NaBH3CN (added last) or 1–5 equiv picoline borane; stir at 20–25°C for 2–18 h.
Notes: Maintain pH; avoid oxygenation; quench residual aldehyde with hydroxylamine or ethanolamine post-reaction.
Hydrazone formation (to hydrazides):
Buffer: 50–100 mM sodium acetate, pH 4.5–5.5.
Catalyst: 10–50 mM aniline (optional) accelerates imine formation.
Time/Temp: 1–6 h at 20–25°C; longer for sterically hindered sites.
Stabilization: Reduce to alkyl hydrazide with NaBH3CN if permanent linkage desired; otherwise, hydrazones are moderately stable near neutral pH.
Oxime ligation (to aminooxy):
Buffer: 50–100 mM acetate, pH 4.5–5.0; aniline catalysis as above.
Kinetics: Typically faster and more hydrolysis-resistant than hydrazones; 0.5–4 h at 20–25°C common.
Surface modification:
Solvent: Water, ethanol/water, or anhydrous DMF depending on substrate.
Workup: Rinse thoroughly; block unreacted aldehyde with hydroxylamine.
Purification:
Proteins: Dialysis or ultrafiltration (10–100 kDa MWCO depending on conjugate).
Small molecules: SEC, precipitation, or spin filtration.
Expected yields are system-dependent; conversion is best monitored by MS (for biomolecules), TNBS assays for free amines, or colorimetric carbonyl assays.
Safety and Handling
GHS classification, signal word, pictograms, H-statements: Not specified for this item; refer to the product SDS for authoritative safety information.
General safety guidance for PEG-aldehyde reagents (literature/best practice; not product-specific):
Hazards: PEGs are generally of low acute toxicity and low volatility; the terminal aldehyde is an electrophile that can cause irritation or sensitization upon skin/eye contact and may react with biological amines.
PPE: Wear lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Use in a fume hood when weighing or preparing solutions, especially if using volatile co-solvents (DMF, DMSO, ACN).
Handling: Minimize exposure to air and moisture to preserve aldehyde integrity. Work quickly with containers kept under inert gas where feasible. Avoid amine-containing buffers (e.g., Tris) during bioconjugation setup.
Incompatibilities: Strong oxidizers (risk of aldehyde oxidation), strong bases (can promote aldol-type side reactions), and nucleophiles (amines) unless intended for conjugation. Avoid prolonged exposure to light and elevated temperature.
First aid (overview; consult SDS): Eye/skin contact—rinse with water for at least 15 minutes; remove contaminated clothing. Inhalation—move to fresh air. Ingestion—not intended for ingestion; seek medical attention.
Waste: Collect PEG-containing and aldehyde-containing waste in labeled containers; dispose per institutional and local regulations.
Special risks: Peroxide formation is not a known issue for PEGs; primary concern is aldehyde oxidation/hydrate formation and unintended reaction with nucleophiles.
Solvent Selection
mPEG propionaldehyde is a nonionic, highly hydrophilic polymer; the aldehyde terminus allows conjugation in aqueous or mixed solvents.
Polarity/miscibility (literature):
Readily soluble in water and polar organics (DMSO, DMF, methanol, ethanol, acetonitrile).
Limited solubility in nonpolar media (e.g., alkanes, toluene), though small amounts may dissolve depending on MW.
Choosing solvents by application:
Bioconjugation to proteins/biomolecules: Prefer aqueous buffers (acetate pH ~4.5–5.5 for hydrazone/oxime; phosphate pH ~6–7 for reductive amination). Add ≤10–30% DMSO or DMF as cosolvent if needed to solubilize higher-MW PEG.
Surface modification (amines on resins/particles): Water, ethanol/water, or DMF are commonly used; select to wet the surface effectively.
Small-molecule coupling or polymer–polymer ligation: Anhydrous DMF, DMSO, or ACN enable controlled stoichiometry and exclude adventitious water.
Buffer cautions:
Avoid primary amine buffers (Tris, glycine) that compete with target amines and quench aldehyde reactivity.
Include salt (e.g., 100–150 mM NaCl) to maintain protein stability when needed.
Practical tips:
Degas and pre-equilibrate solvents to minimize dissolved oxygen (limits oxidation to acids).
For highly viscous solutions at high concentration, warm gently (≤30–37°C) and mix slowly to avoid air entrainment.
Storage and Reconstitution
From Product Data (authoritative for this item):
Storage conditions: Protect from light; store at −20°C; supplied argon charged.
Shipping: Ice chest + ice pads.
Practical storage guidance (general best practices for PEG-aldehydes):
Keep container tightly sealed under inert gas (argon or nitrogen) with desiccant. Minimize headspace oxygen and moisture to limit oxidation to acids and hydrate formation.
Avoid repeated freeze–thaw cycles. If frequent use is expected, subdivide into single-use aliquots under inert atmosphere.
Reconstitution and solution handling (general):
Solvents: Use anhydrous water, PBS/phosphate buffer (if immediate use), or dry DMF/DMSO/ACN as required. For bioconjugation, prepare fresh solutions immediately before use.
Concentration: Adjust based on application; 1–100 mM stock solutions are common in organic media; for aqueous stocks, prepare as needed to minimize aldehyde hydration.
Filtration: If sterile solutions are required for biomolecule work, 0.22 µm filter under inert gas pressure when feasible.
Stability of solutions: Aldehyde solutions in water gradually hydrate/oxidize; use within the working day. Organic anhydrous stocks can be stored short-term at −20°C under inert gas, but prepare fresh when possible.
Quenching/cleanup: After coupling, quench unreacted aldehyde (e.g., hydroxylamine or ethanolamine) and remove small molecules by dialysis/ultrafiltration.
Research use only: Not for human or veterinary use.
Structure and Identity
mPEG propionaldehyde is a monofunctional polyethylene glycol (PEG) derivative bearing a terminal propionaldehyde group for covalent conjugation, with a methoxy cap on the opposite terminus.
Item-specific identifiers from Product Data:
CAS: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet. (Note: mPEG reagents are typically polydisperse and offered by nominal MW.)
SMILES / InChIKey: Not specified for this item; refer to CoA/Spec Sheet. (Not uniquely defined for polymers.)
Structural features (general, literature):
Backbone: Repeating ethylene oxide units –(CH2–CH2–O)–n– (PEG chain).
Termini: One end is methoxy-capped (–O–CH3), the other terminates in a propionaldehyde handle (–CH2–CH2–CHO) via a short alkyl spacer from the PEG chain (–O–(CH2CH2O)n–CH2–CH2–CHO; schematic, literature).
Topology: Flexible, non-ionic, water-soluble polymer; no defined stereocenters; polydisperse distribution in n.
2D structure in words:
A linear poly(ethylene glycol) chain with one end capped by a methoxy group (mPEG) and the other end bearing a propionaldehyde moiety. The aldehyde carbonyl (–CHO) is separated from the PEG chain by a two‑carbon linker, improving accessibility for conjugation with primary amines, hydrazides, or aminooxy groups (literature).
Synthetic Utility
From a synthetic perspective, mPEG propionaldehyde is a versatile monofunctional polymeric building block enabling installation of a single PEG chain onto diverse nucleophilic substrates.
Functional group profile:
Electrophile: Terminal aldehyde (–CHO) reacts with primary amines (Schiff base formation → reduction), and with hydrazide/aminooxy partners (hydrazone/oxime formation) under mild conditions.
Inert tail: Methoxy-capped PEG end does not participate in further reactions, ensuring monoconjugation.
Retrosynthetic value:
Allows late-stage diversification of complex molecules/materials with minimal perturbation of core functionality.
Facilitates introduction of hydrophilicity and steric bulk in a single step.
Representative transformations (literature):
Protein/peptide modification via reductive amination at lysine ε-NH2.
Solid support and nanoparticle functionalization using surface amines (e.g., silica–APTES, amine resins) to yield antifouling coatings.
Ligation to aminooxy- or hydrazide-tagged small molecules/polymers to construct block copolymers or ligands with defined spacing.
Advantages vs. other PEG handles:
Compared with NHS-ester PEGs, aldehyde PEGs offer greater hydrolytic stability in storage and enable on-demand capture of amines with tunable reversibility prior to reduction.
Compared with azide/alkyne click handles, aldehyde chemistry avoids copper catalysts and proceeds in water at mild pH, though selectivity must be managed.
Guidance: Choose nominal MW, linker length, and reaction manifold (reductive amination vs. oxime/hydrazone) based on substrate sensitivity and desired linkage stability.
Target Specificity
Not applicable. This product is a chemical conjugation reagent, not a biological affinity reagent or antibody. It does not possess inherent target specificity beyond generic chemoselectivity for nucleophiles (primary amines, hydrazides, aminooxy groups). For application-specific targeting, combine with substrates bearing the desired recognition elements.
Domande frequenti
How should this product be stored?
Store at ?20 °C, protected from light, under argon. It is supplied under an argon blanket; reseal under inert gas after each use.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Utilizziamo i cookie per garantire il corretto funzionamento del sito web e, ove consentito, per migliorare la tua esperienza. Puoi gestire le tue preferenze in qualsiasi momento nelle Impostazioni. Per saperne di più, consulta la nostra Cookie Policy.
Desidera che le inviamo un messaggio quando avremo sconti disponibili?
Ricordamelo più tardi
Grazie! Controlli la sua casella di posta per confermare.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.